Warning from PDEA: Public Urged to Avoid Cannabis Oil E-cigarettes

Regulations by 2FIRSTS.ai
Apr.24.2024
Warning from PDEA: Public Urged to Avoid Cannabis Oil E-cigarettes
PDEA warns against illegal e-cigarette pods containing cannabis oil in the Philippines, crackdown underway on illegal drug trade.

According to a report from Gov.ph on April 22, the Philippine Drug Enforcement Agency (PDEA) has warned the public against using e-cigarettes containing cannabis oil.

 

The director of the Soksalgen region, Aileen Lovitos, emphasized that the use of cannabis oil e-cigarette products violates Articles 5 (illegal sale of dangerous drugs) and 11 (possession of dangerous drugs) of Republic Act No. 9165, also known as the Comprehensive Dangerous Drugs Act of 2002. Anyone found selling or possessing such products will face corresponding legal consequences.

 

Recently, the department seized 51 e-cigarette pods containing suspicious marijuana oil from three suspects in a crackdown operation. The estimated value of the illegal products seized was as high as 178,500 Philippine pesos ($3,101.39), with each e-cigarette pod selling for up to 3,500 Philippine pesos ($60.81).

 

Currently, the bureau is collaborating with various law enforcement agencies and national government departments to monitor physical and online e-cigarette stores. According to Lovitos, illegal traders often conduct transactions through the "kaliwaan" scheme or online platforms, using private vehicles, packages, drug dens, cheap motels or hotels for delivery, and sell illegal drugs online using social media or courier services.

 

According to a report by the agency, in the first quarter of this year, Philippine law enforcement agencies seized illegal drugs worth approximately 2.5 million Philippine pesos ($43,436.85 USD). From January to March, a total of 375.6643 grams of methamphetamine and 11.884 grams of dried marijuana leaves were confiscated in 25 anti-drug operations, resulting in the successful apprehension of 30 individuals involved in drug-related activities.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
BAT FY2025 Results Review Series by 2Firsts
BAT FY2025 Results Review Series by 2Firsts
Feb.12
Coalition pushes back on Hochul’s proposed 75% wholesale tax on alternative nicotine products
Coalition pushes back on Hochul’s proposed 75% wholesale tax on alternative nicotine products
A coalition of business owners and former law enforcement officers protested Gov. Kathy Hochul’s proposed 75% wholesale tax on alternative nicotine products, saying it would fuel organized crime and burden low-income New Yorkers, while supporters said it would curb addiction and help fund hospitals.
Feb.28 by 2FIRSTS.ai
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
E-cigarette brand MASKKING has recently listed its new UCEE MAX on its official website. According to the website, the device features an open, refillable design with a stated 10 mL e-liquid capacity, supports three refills, and claims a total of 60,000 puffs.
Mar.02 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24